Key Takeaways
- QuantumScape (QS) shares declined 7% Monday, settling at $4.56 and marking a new 52-week low of $4.54 intraday.
- Year-to-date losses have reached approximately 56%, with Monday’s decline occurring without specific corporate catalysts.
- TD Cowen lowered its price objective to $6 while maintaining a Hold recommendation; Wall Street consensus remains cautious at Hold.
- Company insiders offloaded more than 321,000 shares valued at roughly $2 million during the last three months, though certain institutional holders increased stakes.
- QuantumScape maintains its 2029 target for full-scale manufacturing alongside Volkswagen’s PowerCo, with Honda joining as a research partner in June.
QuantumScape (QS) stock experienced a sharp 7% decline Monday, finishing the trading day at $4.56. The shares reached a new annual low of $4.54 during intraday trading.
QuantumScape Corporation, QS
The solid-state battery developer has shed roughly 56% of its value year-to-date. Monday’s selloff wasn’t triggered by any specific corporate disclosure.
Rather, market participants seem to be reassessing the extended timeline before QuantumScape achieves full-scale manufacturing. The company has been publicly traded for several years without achieving profitability.
Volume metrics also reflected subdued interest. Approximately 7 million shares traded hands, significantly below the typical daily average of nearly 19 million units.
TD Cowen reduced its price objective on the shares from $8 down to $6 in July. The investment firm maintained its Hold stance.
The broader analyst community remains cautious. With five analysts assigning Hold ratings and one recommending Sell, the consensus stands at Reduce with an average price target around $9.47.
Mounting Losses Continue to Weigh on QS Stock
QuantumScape continues to burn substantial cash as it advances its battery platform. The firm reported a net loss of $98.2 million during Q2.
Looking ahead to 2026, management projects an adjusted EBITDA loss ranging from $250 million to $275 million. That represents a significant deficit the company must eventually eliminate.
On a more encouraging note, QuantumScape finished the quarter with $859 million in available liquidity. Management also reduced its 2026 capital expenditure guidance to between $27 million and $37 million.
The company restructured its arrangement with Volkswagen’s PowerCo in July as well. Milestone compensation was trimmed from approximately $131 million to $75 million, though QuantumScape contends that reduced project expenses should compensate for the decrease.
Revenue indicators have trended more favorably. Q2 billings totaled $10.8 million, bringing first-half billings to $21.8 millionāalready surpassing the $19.5 million recorded for the entire 2025 fiscal year.
Expanding Partnerships and Production Capabilities
The company aims to double cell production from its Eagle Line facility throughout the second half of 2026. Increased output will generate additional testing data for both QuantumScape and its automotive partners.
Honda executed a multi-year research partnership with QuantumScape in June following an evaluation of the battery platform. This supplements ongoing collaboration with Volkswagen’s PowerCo division.
QuantumScape is simultaneously engaged with two additional major automotive manufacturers. The company has delivered cell samples to one more carmaker for validation testing.
CEO Siva Sivaram has reiterated that the company anticipates reaching commercial-scale production with PowerCo by 2029. That timeline represents the critical inflection point for the operation.
Executive selling has continued during the recent price weakness. CTO Timothy Holme disposed of 45,000 units in mid-September at an average price of $5.09 per share.
CFO Kevin Hettrich sold 9,800 units in July at an average of $7.28 per share. Collectively, insiders have sold 321,644 units valued at nearly $2 million over the preceding 90 days.
Institutional participants have moved in the opposite direction. Dimensional Fund Advisors expanded its holdings by more than 134% during Q1, while Geode Capital Management also increased its position.
Company insiders presently control approximately 3.93% of outstanding shares. Institutional investors and hedge funds collectively own close to 29.87% of the equity.





